HPV vaccine introduction in Rwanda: Impacts on the broader health system

Sexual and Reproductive Healthcare

Volumn 7, Issue , 2016, Pages 46-51

  Torres Rueda, Sergio ^a   Rulisa, Stephen ^b,c   Burchett, Helen E D ^c   Mivumbi, N Victor ^d   Mounier Jack, Sandra ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF RWANDA   (Rwanda)

^c University Teaching Hospital of Kigali   (Rwanda)

^d Ministry of Health   (Rwanda)

Author keywords

Adolescent health; Health systems; HPV; Rwanda; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; FINANCIAL MANAGEMENT; FORECASTING; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE MANPOWER; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH PROMOTION; HUMAN; IMMUNIZATION; MEDICAL INFORMATION SYSTEM; MEDICAL STAFF; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROGRAM SUSTAINABILITY; QUESTIONNAIRE; REMUNERATION; RWANDA; SATISFACTION; SCHOOL HEALTH SERVICE; SEMI STRUCTURED INTERVIEW; STAFF TRAINING; WASTE DISPOSAL; WORKLOAD; ADOLESCENT; CHILD; COMMUNITY CARE; FEMALE; HEALTH CARE FACILITY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVENTIVE HEALTH SERVICE; SCHOOL; UTERINE CERVICAL NEOPLASMS; VACCINATION; VIROLOGY;

ADOLESCENT; CHILD; COMMUNITY HEALTH SERVICES; DELIVERY OF HEALTH CARE; FEMALE; HEALTH FACILITIES; HEALTH PROMOTION; HUMANS; IMMUNIZATION PROGRAMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RWANDA; SCHOOLS; SURVEYS AND QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84949685532     PISSN: 18775756     EISSN: 18775764     Source Type: Journal    
DOI: 10.1016/j.srhc.2015.11.006     Document Type: Article

References (35)

1. Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., et al. GLOBOCAN 2012 v.10 cancer incidence and mortality worldwide: IARC CancerBase No. 11 2013, [Internet], International Agency for Research on Cancer, Lyon, France. http://globocan.iarc.fr.
2. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55(4):244-265.
3. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348(6):518-527.
4. Paavonen J., Naud P., Salmeron J., Wheeler C.M., Chow S.N., Apter D., et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009, 374(9686):301-314.
5. World Health Organization WHO Prequalified Vaccines accessed 11.08.15. http://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_list_en/en/.
6. Garland S.M., Hernandez-Avila M., Wheeler C.M., Perez G., Harper D.M., Leodolter S., et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007, 356(19):1928-1943.
7. Financing HPV vaccination in developing countries. Lancet 2011, 377(9777):1544. Editorial.
8. GAVI Alliance Total Commitments: inception to February 28, 2014 accessed 09.04.14. http://www.gavialliance.org/country/rwanda/.
9. Binagwaho A.W.C., Gatera M., Karema C., Nutt C., Ngabo F. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ 2012, 90(8):623-628.
10. Ministry of Health Republic of Rwanda Vaccine Preventable Diseases Division: Comprehensive Multi-Year Plan 2013-2017 2012.
11. Wang S., Hyde T., Mounier-Jack S., Brenzel L., Favin M., Gordon S., et al. New vaccine introductions: assessing the impact and the opportunities for immunization and health systems strengthening. Vaccine 2013, 31S(2013):B122-8.
12. Marchal B., Van Dormael M., Pirard M., Cavalli A., Kegels G., Polman K. Neglected tropical disease (NTD) control in health systems: the interface between programmes and general health services. Acta Trop 2011, 120(Suppl. 1):S177-85.
13. Mounier-Jack S., Rudge J.W., Phetsouvanh R., Chanthapadith C., Coker R. Critical interactions between Global Fund-supported programmes and health systems: a case study in Lao People's Democratic Republic. Health Policy Plan 2010, 25(Suppl. 1):i37-42.
14. Hanvoravongchai P., Mounier-Jack S., Oliveira Cruz V., Balabanova D., Biellik R., Kitaw Y., et al. Impact of measles elimination activities on immunization services and health systems: findings from six countries. J Infect Dis 2011, 204(Suppl. 1):S82-9.
15. Hyde T.B., Dentz H., Wang S.A., Burchett H.E., Mounier-Jack S., Mantel C.F. The impact of new vaccine introduction on immunization and health systems: a review of the published literature. Vaccine 2012, 30(45):6347-6358.
16. Burchett H.E.D., Mounier-Jack S., Torres-Rueda S., Griffiths U.K., Ongolo-Zogo P., Rulisa S., et al. The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countries. Vaccine 2014, 32(48):6505-6512.
17. World Health Organization Everybody's business: strengthening health systems to improve health outcomes. WHO's Framework for Action 2007, World Health Organization., Geneva.
18. WHO ad hoc working group on impact of new vaccines on health systems. Impact of new vaccine introduction on immunization and health systems: summary of main themes and findings from 5 data sources by WHO health system building blocks. http://www.who.int/immunization/sage/meetings/2012/april/1_Summary_Main_Themes_23March.pdf.
19. World Health Organization New vaccine post-introduction evaluation, (PIE) 2010, Geneva. http://whqlibdoc.who.int/hq/2010/WHO_IVB_10.03_eng.pdf.
20. Umea University Open code 2011, [Online], Umea University, Umea, Sweden.
21. Ladner J., Besson M.H., Rodrigues M., Audureau E., Saba J. Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013. BMC Public Health 2014, 14:670.
22. MacPhail C., Pettifor A., Moyo W., Rees H. Factors associated with HIV testing among sexually active South African youth aged 15-24 years. AIDS Care 2009, 21(4):456-467.
23. Denison J.A., McCauley A.P., Dunnett-Dagg W.A., Lungu N., Sweat M.D. HIV testing among adolescents in Ndola, Zambia: how individual, relational, and environmental factors relate to demand. AIDS Educ Prev 2009, 21(4):314-324.
24. Broutet N., Lehnertz N., Mehl G., Camacho A.V., Bloem P., Chandra-Mouli V., et al. Effective health interventions for adolescents that could be integrated with human papillomavirus vaccination programs. J Adolesc Health 2013, 53(1):6-13.
25. MacPhail C., Venables E., Rees H., Delany-Moretlwe S. Using HPV vaccination for promotion of an adolescent package of care: opportunity and perspectives. BMC Public Health 2013, 13:493.
26. Binagwaho A., Fuller A., Kerry V., Dougherty S., Agbonyitor M., Wagner C., et al. Adolescents and the right to health: eliminating age-related barriers to HIV/AIDS services in Rwanda. AIDS Care 2012, 24(7):936-942.
27. Kalesha-Masumbu P.(Ed.). HPV vaccination program in Zambia. New vaccines introduction: decision-making & impact on health systems 2013, London.
28. Binagwaho A., Ngabo F., Wagner C.M., Mugeni C., Gatera M., Nutt C.T., et al. Integration of comprehensive women's health programmes into health systems: cervical cancer prevention, care and control in Rwanda. Bull World Health Organ 2013, 91(9):697-703.
29. Markowitz L.E., Tsu V., Deeks S.L., Cubie H., Wang S.A., Vicari A.S., et al. Human papillomavirus vaccine introduction-the first five years. Vaccine 2012, 30(Suppl. 5):F139-48.
30. World Bank World DataBank 2014.
31. National Institute of Statistics, Ministry of Health of Rwanda, Macro International Inc Rwanda demographic and health survey 2010 dataset 2010.
32. World Health Organization Health workforce data and statistics 2014.
33. Levin C.E., Van Minh H., Odaga J., Rout S.S., Ngoc D.N., Menezes L., et al. Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam. Bull World Health Organ 2013, 91(8):585-592.
34. Hutubessy R., Levin A., Wang S., Morgan W., Ally M., John T., et al. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool. BMC Med 2012, 10:136.
35. GAVI Alliance Supplementary guidelines for human papillomavirus (HPV) vaccine demonstration project applications in 2014 2014.